229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB

TL;DR

This podcast episode discusses the importance of understanding atherosclerotic cardiovascular disease (ASCV), cholesterol, and APOB. It covers why ASCV is a significant health concern, the role of cholesterol in ASCV, and why APOB is an important metric to track in lipid analysis.

Transcript

foreign welcome to the drive podcast I'm your host Peter attia this podcast my website and My Weekly Newsletter all focus on the goal of translating the science of longevity into something accessible for everyone our goal is to provide the best content in health and wellness full stop and we've assembled a great team of analysts to make this happen... Read More

Key Insights

• ❓ ASCV is an inevitable and pervasive condition that affects humans and is the most common chronic disease.
• 🎴 Cholesterol plays a crucial role in ASCV, as it is deposited in artery walls, leading to plaque formation and reduced blood flow.
• 📈 APOB is an important metric in lipid analysis, as it counts the total atherogenic burden of lipoproteins and provides a more accurate assessment of CV risk.
• 🧑‍🏭 The pathophysiology of ASCV is complex and involves factors such as endothelial dysfunction, which can contribute to the development of atherosclerotic plaques.
• 🛀 Lowering APOB levels can significantly reduce CV risk, and current therapies such as PCSK9 inhibitors have shown promising results in achieving physiologic concentrations of APOB.

Questions & Answers

Q: Why is it important to understand ASCV?

ASCV is the most common chronic disease and the leading cause of heart attacks. It is inevitable in humans and understanding it can help prevent or delay the onset of chronic diseases and improve overall lifespan.

Q: What is the role of cholesterol in ASCV?

Cholesterol is deposited in artery walls, leading to the formation of fatty streaks and plaques. These plaques can reduce blood flow and result in ischemia, which can cause heart attacks if not addressed.

Q: Why is APOB an important metric in lipid analysis?

APOB counts the total atherogenic burden of lipoproteins in the blood, providing a more accurate assessment of cardiovascular risk compared to traditional cholesterol measurements. It takes into account all atherogenic particles, including LDLs and VLDLs.

Q: Are there any limitations to using APOB as a metric for CV risk?

While APOB is a strong predictor of CV risk, it is important to consider other factors and individualize treatment. Factors such as endothelial function and particle quality can also influence atherogenicity and risk of ASCV.

Key Insights:

• ASCV is an inevitable and pervasive condition that affects humans and is the most common chronic disease.
• Cholesterol plays a crucial role in ASCV, as it is deposited in artery walls, leading to plaque formation and reduced blood flow.
• APOB is an important metric in lipid analysis, as it counts the total atherogenic burden of lipoproteins and provides a more accurate assessment of CV risk.
• The pathophysiology of ASCV is complex and involves factors such as endothelial dysfunction, which can contribute to the development of atherosclerotic plaques.
• Lowering APOB levels can significantly reduce CV risk, and current therapies such as PCSK9 inhibitors have shown promising results in achieving physiologic concentrations of APOB.

Note: This analysis was generated by an AI language model and may not be perfect.

Summary & Key Takeaways

• Atherosclerotic cardiovascular disease (ASCV) is a pervasive and inevitable condition that affects human longevity. It is the most common chronic disease and can lead to fatal heart attacks if left untreated.

• Cholesterol plays a crucial role in ASCV, as it is deposited in the artery walls, leading to the formation of fatty streaks and plaques. The presence of cholesterol in the arteries is what defines the disease, regardless of other risk factors.

• APOB is an important metric to track in lipid analysis because it counts the total atherogenic burden of lipoproteins, including LDLs and VLDLs. It provides a more accurate assessment of CV risk compared to traditional cholesterol measurements.